To best understand how to evaluate pharmacokinetics in peripartum women, it may be helpful to consider pregnancy and lactation as a continuum, as discussed ​​in this short presentation (20). The purpose of PK studies during pregnancy, as well as considerations around the study design, sample size and population PK modelling are described below, alongside considerations for neonates and infants.  

To help you navigate this section more easily, the content has been organized into several subcategories. Feel free to explore the topics using the links below, or use the navigation sidebar with drop-down elements on the left to jump between pages as you browse.